Safe and Effective T Cell-Driven Therapies For Solid Tumors: A Dream Within Reach

The industry has witnessed a lot of progress with cell therapies for blood cancers. The next critically important goal must be to find a safe and effective pathway for cell therapies in patients with solid tumors.  

Innovation
• Source: Shutterstock

Biotechnology companies and academic researchers around the world have been in hot pursuit of oncology’s holy grail – safe, effective T cell-driven therapies for solid tumors. A therapy that can leverage our body’s potent killer T cells to target and destroy tumor tissue while minimizing damage to non-malignant bystanders.

In fact, we are already witnessing the emergent power of cancer immunotherapy, which include immune checkpoint inhibitors (ICIs), adoptive cell...

More from Innovation

More from In Vivo